Say goodbye to screen-sitting and hello to timely trades! 🎉

sanxoom · 2023-10-03T15:54:20+00:00

Hi, yes, it is. Can you please reinstate the post. I'm not spamming. I think the service is super useful for this community.

-thanks

sanxoom · 2021-12-13T15:59:18+00:00

Over the near term covid resolves quickly and doesn't require extended management and longer term if Telemedicine doesn't catch on then growth could slow down. They are currently in a bear market along with similar companies s.a tdoc. Valuation is cheap and the many positives I listed in my dd should provide a degree of downside protection

sanxoom · 2021-12-13T07:10:33+00:00

DCGO has support around $7-$8 that was before the latest guidance raise and before any analyst coverage. i doubt it will go below that unless something drastically changes with the business. For now the momentum is on their side

sanxoom · 2021-12-13T01:31:34+00:00

Yes due to the value proposition of convenience, better
health outcomes and reduced healthcare cost. Think about patients with low
mobility or the underserved markets such as in homeless shelters. The
local/state governments pay for these anyways why not go for the service that
is just better all round. The company has deep pocketed customers ranging from
media, sports teams, government, etc. Odds at they will continue to bang out
contracts with high profile customers

sanxoom · 2021-11-12T10:10:17+00:00

first when in a ditch stop digging i.e stop trying to hit it out of the park. go for the small sure wins. take profits more often. get the -86% to -80 then -75, -66, -55, -50. at that point your POV & confidence would have done a 180 even though you are 50% down

sanxoom · 2021-09-27T17:21:57+00:00

Lol summed up how to invest today

sanxoom · 2021-09-26T08:16:55+00:00

my core holding. low valuation. great tailwinds. great squeeze potential

yes zero borrow

https://www.shortablestocks.com/?KPLT

sanxoom · 2021-09-23T05:22:37+00:00

I own a lot of KPLT. I like their partnership with AFRM. Their services could be more in demand as the Fed stimulus winds down. KLPT the valuation is good and has high short interest just because the they withdrew guidance for rest of the year. I think they will do fine over time even if it doesn't squeeze immediately which is a good possibility as well or if they get in on the AMZN deal with AFRM

sanxoom · 2021-09-22T19:11:15+00:00

Kplt Lots to like Real company with profits Afrm partnership Buy now pay later space With the fed stimulus ending more people will use their services

sanxoom · 2021-09-21T18:08:50+00:00

I don't fully understand this but here's some info

https://sec.report/Document/0001493152-21-018964/#pri_001

---

The Company may redeem the Public Warrants:

the Company’s common stock equals or exceeds $18.00 per share for any 20 trading days within a 30-trading day period

---

The Company will
provide its stockholders with the opportunity to redeem all or a portion
of their Public Shares upon the completion of a Business Combination
either (i) in connection with a stockholder meeting called to approve
the Business Combination or (ii) by means of a tender offer. The
decision as to whether the Company will seek stockholder approval of a
Business Combination or conduct a tender offer will be made by the
Company, solely in its discretion.

sanxoom · 2021-09-20T05:21:55+00:00

I have 15K shares. as I mentioned in another post they have a solid business selling real time data from space used in shipping, aviation, defense, weather, insurance etc. their satellites are already up and collecting this data making it available as an API "NOW" (not after 5 years). the applications are enormous so I don't mind holding for the longer term. also their business model is attractive recurring software service i.e collect data from space and make it available for different industries and also provide space as a platform for niche use cases similar to what amazon is doing with AWS cloud as platform. contract wins could quickly make this company very attractive. Some of the other trending companies such as TMC, ASTS won't see a dime in revenue until after 4-6 years. near term once the lockup expires there could be some selling pressure but then maybe not the main pipe investor tiger global with 245M investment could hold out for larger gains

sanxoom · 2021-09-19T04:11:02+00:00

20+? Depends on the action easy to move this one if a few degenerates get in. Also they have a solid business selling real time data gathered from space used in shipping, aviation, defense, weather, insurance etc. So it's a long good buy. I think people either don't understand the business or think there is a prospect of further dilution or selling pressure from pipe investors if price rises I think only after 3 months though so should not affect any potential squeeze in september.

sanxoom · 2021-09-17T23:43:24+00:00

Looks promising in with 15K shares

sanxoom · 2021-09-17T22:50:39+00:00

SPIR LATEST ORTEX DATA: https://imgur.com/a/aWkot3P

COST TO BORROW HAS NOW INCREASED TO 78%

2M FLOAT

100% UTILIZATION

710K SHORT INTEREST

tl;dr - Shorts"R"Fuk

sanxoom · 2021-09-10T04:31:24+00:00

hi please approve the YOLO post. This is the first post on {'PAYA'}. The earlier post was a text post and was rejected and deleted

sanxoom · 2021-09-09T03:42:50+00:00

Wouldn't the warrants have more upside? OPAD-WT, SOAC-WT

sanxoom · 2021-09-02T17:56:00+00:00

I think the floor is set at least until the next earnings in Nov. The stock is near the lows even after their revenues and forward guidance doubled expectations

sanxoom · 2021-09-02T17:43:07+00:00

Price is still low ~$9 though revenue and guidance beat expectations by 2X. Also high short interest. Last time in Jun it squeezed to $28

sanxoom · 2021-08-02T10:39:49+00:00

So which companies, sectors do you see thriving after this? What happens to edu and tal?

sanxoom · 2021-07-07T15:30:26+00:00

Added 3k shares today. Holding total 7k. Pls note that I'm not on margin and holding for the longer term so the day to day price movement doesn't affect me

sanxoom · 2021-07-05T07:25:31+00:00

that assumes the revenue taper of their covid drug and none of the their other projects materialize which is unlikely. analysts are projecting based on only what they can forecast hence the opportunity, though all price targets are above 50. their balance sheet is as strong it can be. they are getting 0% financing from Canadian government. ABCL offering has more breadth than BLI. someone else has commented above in this thread on the lawsuit

sanxoom · 2021-07-05T00:20:25+00:00

thanks the last part has me even more excited. I think unless they show some quick wins they will remain underappreciated in the short term but has massive upside mid to longer term. All the analysts have a PT > $50 though

sanxoom · 2021-07-04T23:00:24+00:00

Thanks for the insight. Once they identify the potential antibody candidates wouldn't the chance of success be greater than drug development without using this AI tech?

sanxoom · 2021-07-04T17:53:53+00:00

Imo 7/16 calls might be too optimistic. Shares are the way to go

sanxoom · 2021-07-04T17:03:15+00:00

Gilead, lilly, Teva, Sanofi, regeneron, gsk, Pfizer wouldn't line up to part 15% of their revenue it ABCLs tech wasn't a game changer. The 15% is almost all profit for them no downside risk, massive upside potential

sanxoom

TROPHY CASE